Speakers
Charles Makin
Global Head, Medical Health Outcomes
Biogen
Day One
Wednesday, October 27
9:15 am | The 10-Year Journey of Real-World Evidence (RWE) in Pharma & Beyond, & Building for the Next 10 Years
Kraig Kinchen
Senior Director, Center of Expertise, Global Patient Outcomes & Real World Evidence
Eli Lilly
Day One
Wednesday, October 27
2:30 pm | Demonstrating the Value of Real-World Evidence to Clinical Colleagues
Day Two
Thursday, October 28
12:30 pm | Roundtable: Turning Your RWE into Actionable Insights & Value Propositions For Patients & Payors
Kelly Zou
Head of Global Medical Analytics & Real World Evidence
Viatris
Day One
Wednesday, October 27
4:30 pm | Chair’s Closing Remarks
9:00 am | Chair’s Opening Remarks
Day Two
Thursday, October 28
3:15 pm | Chair’s Closing Remarks
11:30 am | Incorporating Real World Evidence to Drive Patient Outcomes Research
9:15 am | Panel Discussion: Reviewing Best Practice When Analyzing Real World Data
9:00 am | Chair’s Opening Remarks
Robertino Mera-Giler
Head Biostatistics, Epidemiology, RWE
Freenome Inc.
Day Two
Thursday, October 28
2:45 pm | Designing Synthetic Arm Trials Using Real World Evidence
Bindu Kalesan
Chief Executive Officer
Tury Sciences
Day One
Wednesday, October 27
1:30 pm | Utilizing Real-World Evidence to Gain a Greater Understanding of Patient Populations
Paul Petraro
Executive Director, Real World Evidence Analytic Centre of Excellence
Boehringer Ingelheim
Day One
Wednesday, October 27
11:15 am | Panel Discussion: Understanding the Data Quality Required
9:45 am | Reimagining Your Clinical Trial by Embracing Real-World Data
Eric Sarpong
Director Real World Data Analytics & Innovation, Center for Observational & Real World Evidence
Merck
Day Two
Thursday, October 28
10:30 am | Statistical, Econometrics Methods & Techniques for the Analysis of RWE & RWD
9:15 am | Panel Discussion: Reviewing Best Practice When Analyzing Real World Data
Lee Severson
Global Regulatory Lead, Global Product Strategy
CSL Behring
Day Two
Thursday, October 28
9:15 am | Panel Discussion: Reviewing Best Practice When Analyzing Real World Data
Angela Dobes
Vice President, IBD Plexus
Crohn’s & Colitis Foundation
Day One
Wednesday, October 27
4:00 pm | Partnering to Democratize Data & Accelerate Research
Lina Titievsky
Senior Director, RWE
Vertex Pharmaceuticals
Stuart Turner
Executive Director RWE & Data Science
Novartis
Day Two
Thursday, October 28
2:15 pm | Utilizing RWE in Breast Cancer Treatment Research
12:30 pm | Roundtable: Turning Your RWE into Actionable Insights & Value Propositions For Patients & Payors
Stuart McCully
CSO
Real-World Research Ltd.
WORKSHOP A: Adapting to Survive the Changing Climate of the Real-World Research Regulatory Environment
Tuesday, October 26, 2021 - 10.00 - 12:30 EDT
Samantha St. Laurent
Director, Oncology Cell & Gene Therapy, Value Evidence & Outcomes
GSK
Day One
Wednesday, October 27
3:30 pm | Assessing the Value of Natural Language Processing
Anand Chokkalingam PhD
Executive Director - Real World Evidence
Gilead Sciences
Day One
Wednesday, October 27
10:15 am | Generating Real World Evidence for COVID-19 Treatments During a Global Pandemic
Yanni Hao
Executive Director, RWE & Data Science
Novartis
Day One
Wednesday, October 27
12:00 pm | Using RWD External Control to Emulate a Target Trial When a Randomized Trial is Not Available: Methodology & Regulatory Engagement in Cell & Gene Therapy
Dr. Rachele Hendricks- Sturrup
Research Director, Real World Evidence
Duke-Margolis Center for Health Policy
WORKSHOP B: RWE Applications 2.0 through Federated Machine Learning
Tuesday, October 26, 2021 - 13:30 - 16:00 EDT
L. Allen Kindman MD. FACC
Vice President, Protocol, Patient and Site Feasibility, Applied Data Science Center
IQVIA
Day One
Wednesday, October 27
2:00 pm | Using Real World Data to Promote Diversity and Inclusivity in Clinical Trials
Day Two
Thursday, October 28
12:30 pm | Roundtable: Turning Your RWE into Actionable Insights & Value Propositions For Patients & Payors
Mohamed Sharaf
EMEA Medical Program Lead
Janssen
Day Two
Thursday, October 28
12:00 pm | Using New Models for RWE in Post-Approval Activities
Jolyon Fairburn-Beech
Director, Real World Evidence Strategic Partnerships
GSK
Day One
Wednesday, October 27
11:15 am | Panel Discussion: Understanding the Data Quality Required
Richard Gliklich, MD
Chief Executive Officer
OM1, Inc
Day Two
Thursday, October 28
10:00 am | "Re-Usable" RWD Networks for Registries, Prospective Research, and Post Marketing Commitments
Dr. Sara Jordan
Senior Researcher, Artificial Intelligence and Ethics
Future of Privacy Forum
Russell Joyce
Director & Principal Consultant
Heath Barrowcliff Consulting
